# Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)

> **NCT00705614** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 2662 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **BIOLOGICAL:** Remicade

## Key facts

- **NCT ID:** NCT00705614
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 2662 (ACTUAL)
- **Last updated:** 2017-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00705614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00705614, "Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00705614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*